Company

Sisram Medical Ltd Expands Asia-Pacific Presence with New Direct Sales Office in Japan

CompanyDeals

Beijing-Based Immupeutics Medicine Secures Tens of Millions in Pre-Series A+ Financing

CompanyDrug

Servier’s Tibsovo Receives FDA Approval for IDH1-Mutated R/R MDS, Expanding Indications

CompanyDrug

Huadong Medicine’s Arcalyst (Rilonacept) Filing for CAPSs Accepted by China’s NMPA

CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ HR20031 Accepted for Review by China’s NMPA for Type 2 Diabetes

CompanyDrug

AstraZeneca’s Imfinzi Gains NMPA Approval for First-Line Cholangiocarcinoma Treatment

CompanyDrug

Hansoh Pharmaceutical’s HS-10511 Tablets for Hypertrophic Cardiomyopathy Cleared for Clinical Trials

CompanyDeals

Chiesi Farmaceutici and Shanghai Pharmaceutical Partner on Distribution at CIIE

CompanyDeals

Bayer Shifts Focus of Recursion Pharmaceuticals Collaboration to Precision Oncology

CompanyDeals

Lizhu Pharmaceutical Cancels ChiNext IPO, Opts for NEEQ Listing for Subsidiary Lizhu Reagent

CompanyDrug

Novo Nordisk Commits Over DKK 42 Billion to Expand Chronic Disease Production in Denmark

Company

Eli Lilly China’s President Benjamin L. Basil to Depart for Personal Reasons